Ronald Trahan retweeted
#PCR2022 MEETUP WITH VENOCK CEO TERRY BARNES AT PCR venock.com/index.php/venous-…
Ronald Trahan retweeted
Congratulations to #JLABSTMC resident @corinnova for shining a spotlight on the importance of life science venture funding jlabs.tv/CorInnova
Ronald Trahan retweeted
Great feature on CorInnova, and plugs for #JLABSTMC, #TMCx "If giving to research, why not invest instead?" - buff.ly/2BqRmm2 via @cltomlinson @HoustonChron
Ronald Trahan retweeted
See why Wellcome Trust invested $6.1 million in CorInnova youtube.com/watch?time_conti… We need a new paradigm for treating Heart Failure. ASAP. @CorInnova
Ronald Trahan retweeted
The future of the medical device industry dlvr.it/Q0n3Md
Ronald Trahan retweeted
Replying to @danielowenrose
@danielowenrose presenting #LimFlow at #HTSL17 on why CLI patients don't necessarily need amputation
Ronald Trahan retweeted
How very disheartening it is to read this: For the ‘new yellow journalists,’ opportunity comes in clicks and bucks wpo.st/sOlF2
Ronald Trahan retweeted
New Investor as ZipLine® Medical Secures $19 Million Financing medlatest.com/?p=17183 #MedicalDevice
Ronald Trahan retweeted
SpineGuard receives E.U. patent for its “smart screw” icont.ac/2LDhE via @MedtechMatters
Ronald Trahan retweeted
Replying to @SanovasInc
Ronald Trahan retweeted
If no means of preventing #Alz is identified, the number of Americans suffering from it is projected to rise from 5.3M today to 13M by 2050.
Ronald Trahan retweeted
Decrease in renal NEPI is associated with electrode number in preclinical studies: cbset.org/company/renaldener… #renaldenervation #medicaldevice
Ronald Trahan retweeted
Need for peri-procedural biomarkers for confirmation of renal denetvation highlighted after Symplicity HTN-3 data presented at #ACC14
Ronald Trahan retweeted
Previous clinical and pre-clinical RDN data still valid; renal denervation community should re-boot after Symplicity HTN-3 #ACC14
Ronald Trahan retweeted
Drugmaker Code Defines Gifts to Doctors as Industry Faces Marketing Probes: Bloomberg Thu, 03/01/12 - 10:40 am dlvr.it/1GMLWD
Ronald Trahan retweeted
Extensive amount of DES investigations, not well-known in US, discussed at EuroPCR. Are US studies to follow? #insidepcr
Ronald Trahan retweeted
Analyst: Medical device sector should outperform in 2010 http://tinyurl.com/ybjasjq #stocks #invest #economy #medicaldevice


















